BIIB033, anti-LINGO-1 antibody, for treatment of relapsing forms of multiple sclerosis: Baseline data of the phase 2 synergy trial

Authors
Category Primary study
JournalNeurology
Year 2015
This article has no abstract
Epistemonikos ID: ff57c4879ed5c3002503f59416227d6af8269c6c
First added on: Feb 07, 2025